Pericardial Effusion with Tamponade Physiology as an Immune-related Adverse Event Secondary to Nivolumab

Nikhil Malhotra, Martin W Schoen, Andrew B Kichura, Nishant Poddar and Tarek Helmy
Additional contact information
Tarek Helmy: Department of Internal Medicine, Saint Louis University School of Medicine, USA

Journal of Cardiology & Cardiovascular Therapy, 2018, vol. 10, issue 5, 103-105

Abstract: The relatively recent development and adoption of immunotherapeutic cancer treatments called immune checkpoint inhibitors has led to a tremendous advancement in cancer therapy..

Keywords: cardiology journal; scholarly articles on cardiology; cardiology citation report; cardiology citations; cardiology medical journals; free cardiology medical journals; cardiology journals; Cardiovascular Therapy; juniper publishers; juniper publishers open access journals (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/jocct/pdf/JOCCT.MS.ID.555800.pdf (application/pdf)
https://juniperpublishers.com/jocct/JOCCT.MS.ID.555800.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:ojocct:v:10:y:2018:i:5:p:103-105

DOI: 10.19080/JOCCT.2018.10.555800

Access Statistics for this article

Journal of Cardiology & Cardiovascular Therapy is currently edited by Sophia Mathis

More articles in Journal of Cardiology & Cardiovascular Therapy from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().